A2A Adenosine Receptors and Equine Sepsis

Award Information

Agency: Department of Agriculture	Branch: N/A	Award ID: 61989	Program Year/Program: 2006 / SBIR
Agency Tracking Number: 2003-00471	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: ADENOSINE THERAPEUTICS, LLC
310 FOURTH STREET NE SUITE 201 CHARLOTTESVILLE, VA 22902
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 2: Fiscal Year: 2006

Title: A2A Adenosine Receptors and Equine Sepsis

Agency: USDA

Contract: 2006-33610-17725

Award Amount: $296,000.00

Abstract:
Endotoxemia (Sepsis) affects horses of all breeds and ages and is the leading causes of death in adult horses and foals. Consequently, its economic impact on the equine industry in the United States is devastating. This project seeks to develop new treatments for this disease.

Principal Investigator:
Robert Thompson
4349519484
rdt@adenrx.com

Business Contact:
Robert S. Capon
CEO
4342209400
rob@adenrx.com

Small Business Information at Submission:

Adenosine Therapeutics, LLC
1670 Discovery Dr., Ste. 212 Charlottesville, VA 22911

EIN/Tax ID:

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No